6533b7d9fe1ef96bd126c081

RESEARCH PRODUCT

Reveglucosidase alfa (BMN 701), a GILT-tagged recombinant human acid alpha glucosidase (rhGAA), evaluation in late-onset Pompe disease: Preliminary clinical efficacy and safety results of an extension study (72-week results)

C. HeusnerW. DummerClaude DesnuelleRichard J. BarohnEugen MengelDrago BratkovicPascal LaforêtDerralynn HughesKe YangBarry J. ByrneMark RobertsTarekegn Hiwot

subject

Neurologybusiness.industryExtension studyPediatrics Perinatology and Child HealthMedicineRecombinant human acid alpha-glucosidaseLate onsetNeurology (clinical)DiseaseClinical efficacybusinessVirologyGenetics (clinical)https://doi.org/10.1016/j.nmd.2015.06.453